Veeva Systems ROA 2012-2025 | VEEV
Current and historical return on assets (ROA) values for Veeva Systems (VEEV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Veeva Systems ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-01-31 | $0.72B | $7.34B | 10.87% |
| 2024-10-31 | $0.67B | $6.45B | 10.71% |
| 2024-07-31 | $0.62B | $6.33B | 10.40% |
| 2024-04-30 | $0.56B | $6.19B | 9.86% |
| 2024-01-31 | $0.53B | $5.91B | 9.84% |
| 2023-10-31 | $0.57B | $5.23B | 11.20% |
| 2023-07-31 | $0.54B | $5.23B | 11.25% |
| 2023-04-30 | $0.52B | $5.02B | 11.47% |
| 2023-01-31 | $0.49B | $4.80B | 11.41% |
| 2022-10-31 | $0.40B | $4.18B | 9.82% |
| 2022-07-31 | $0.39B | $4.12B | 10.29% |
| 2022-04-30 | $0.41B | $4.01B | 11.33% |
| 2022-01-31 | $0.43B | $3.82B | 12.45% |
| 2021-10-31 | $0.43B | $3.37B | 13.37% |
| 2021-07-31 | $0.43B | $3.35B | 13.93% |
| 2021-04-30 | $0.41B | $3.22B | 14.43% |
| 2021-01-31 | $0.38B | $3.05B | 14.44% |
| 2020-10-31 | $0.34B | $2.58B | 14.07% |
| 2020-07-31 | $0.33B | $2.52B | 14.47% |
| 2020-04-30 | $0.31B | $2.41B | 14.89% |
| 2020-01-31 | $0.30B | $2.27B | 15.37% |
| 2019-10-31 | $0.31B | $1.90B | 16.97% |
| 2019-07-31 | $0.29B | $1.86B | 17.17% |
| 2019-04-30 | $0.26B | $1.78B | 16.67% |
| 2019-01-31 | $0.23B | $1.65B | 15.97% |
| 2018-10-31 | $0.20B | $1.40B | 14.99% |
| 2018-07-31 | $0.17B | $1.37B | 13.71% |
| 2018-04-30 | $0.16B | $1.32B | 13.74% |
| 2018-01-31 | $0.15B | $1.23B | 14.11% |
| 2017-10-31 | $0.14B | $1.05B | 14.12% |
| 2017-07-31 | $0.13B | $1.04B | 13.70% |
| 2017-04-30 | $0.10B | $1.00B | 11.70% |
| 2017-01-31 | $0.08B | $0.92B | 9.62% |
| 2016-10-31 | $0.07B | $0.79B | 8.70% |
| 2016-07-31 | $0.05B | $0.79B | 7.53% |
| 2016-04-30 | $0.05B | $0.75B | 8.07% |
| 2016-01-31 | $0.05B | $0.71B | 8.67% |
| 2015-10-31 | $0.05B | $0.63B | 8.41% |
| 2015-07-31 | $0.05B | $0.59B | 8.91% |
| 2015-04-30 | $0.05B | $0.57B | 8.88% |
| 2015-01-31 | $0.04B | $0.55B | 8.26% |
| 2014-10-31 | $0.02B | $0.49B | 5.45% |
| 2014-07-31 | $0.02B | $0.46B | 3.97% |
| 2014-04-30 | $0.01B | $0.44B | 4.17% |
| 2014-01-31 | $0.01B | $0.37B | 5.59% |
| 2013-07-31 | $0.02B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $38.774B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $11.630B | 121.74 |
| Tempus AI (TEM) | United States | $10.119B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.616B | 72.12 |
| IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $1.955B | 12.10 |
| Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
| Schrodinger (SDGR) | United States | $1.732B | 0.00 |
| Phreesia (PHR) | United States | $1.434B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.74 |
| Omnicell (OMCL) | United States | $1.154B | 20.35 |
| 10x Genomics (TXG) | United States | $1.016B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 850.00 |
| Claritev (CTEV) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.03 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |